Covered recipient · General Payments record
JAMES G CHELNIS
Allopathic & Osteopathic Physicians Ophthalmology Ophthalmic Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$199,007.92
- Reported across 218 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $38,993.66 | 26 |
| Consulting Fee | $2,040.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lumenis BE inc | $37,826.45 | 1 |
| ABBVIE INC. | $2,157.24 | 10 |
| Amgen Inc. | $373.04 | 9 |
| MERZ NORTH AMERICA, INC. | $344.66 | 2 |
| ANI Pharmaceuticals, Inc. | $295.59 | 3 |
| Galderma Laboratories, L.P. | $36.68 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.45 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103451004 | CMS |
| ABBVIE INC. | $19.54 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103451006 | CMS |
| ABBVIE INC. | $9.27 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103451008 | CMS |
| ABBVIE INC. | $30.22 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103451010 | CMS |
| ABBVIE INC. | $2,040.00 | 10/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103132797 | CMS |
| ABBVIE INC. | $11.58 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103451012 | CMS |
| ABBVIE INC. | $5.07 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103451014 | CMS |
| ABBVIE INC. | $6.24 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103451016 | CMS |
| ABBVIE INC. | $10.33 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103451018 | CMS |
| ABBVIE INC. | $6.54 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103451020 | CMS |
| Amgen Inc. | $126.41 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547354 | CMS |
| Amgen Inc. | $5.54 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547356 | CMS |
| Amgen Inc. | $18.94 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547358 | CMS |
| Amgen Inc. | $88.42 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547360 | CMS |
| Amgen Inc. | $63.86 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547364 | CMS |
| Amgen Inc. | $19.53 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547362 | CMS |
| Amgen Inc. | $12.73 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547366 | CMS |
| Amgen Inc. | $9.39 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547368 | CMS |
| Amgen Inc. | $28.22 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547370 | CMS |
| ANI Pharmaceuticals, Inc. | $79.62 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091140072 | CMS |
| ANI Pharmaceuticals, Inc. | $79.63 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091167286 | CMS |
| ANI Pharmaceuticals, Inc. | $136.34 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091146566 | CMS |
| Galderma Laboratories, L.P. | $21.73 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145290148 | CMS |
| Galderma Laboratories, L.P. | $14.95 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145290150 | CMS |
| Lumenis BE inc | $37,826.45 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082052968 | CMS |
| MERZ NORTH AMERICA, INC. | $197.01 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146370563 | CMS |
| MERZ NORTH AMERICA, INC. | $147.65 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146370565 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.